We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment

By LabMedica International staff writers
Posted on 16 Mar 2023
Print article
Image: The biosensor could help optimize cancer treatment, identify DNA damage factors, and elucidate repair mechanisms (Photo courtesy of Pexels)
Image: The biosensor could help optimize cancer treatment, identify DNA damage factors, and elucidate repair mechanisms (Photo courtesy of Pexels)

Double-strand breaks (DSBs) are a form of DNA damage in which both strands of DNA break at the same place, adversely affecting cell growth and functioning. Presently, immunostaining techniques are utilized to detect DSBs by identifying the markers accompanying DNA damage, such as the γH2AX protein. Nonetheless, these processes are laborious and incapable of recognizing DSBs in real-time in living specimens.

Scientists from Pusan National University (Busan, South Korea) have invented a new biosensor that utilizes fluorescence resonance energy transfer (FRET) to spot DNA double-strand breaks in real-time in living specimens. The biosensor has the potential to transform cancer treatment by providing doctors with an understanding of how cells respond to therapeutic treatments and also aid in the discovery of new DNA repair drugs. Moreover, the new biosensor can be instrumental in discovering new treatments for DNA damage-related diseases by providing insights into how the human body repairs damaged DNA.

In a 2023 study, published in Biomaterials Research, researchers describe a FRET biosensor that is capable of detecting DSBs in real-time, and providing time- and location-based data on yH2AX. The FRET sensor comprises two fluorescent proteins or dyes - a donor and an acceptor - which examine the interactions between biological molecules. The energy transfer, and consequently, the amount of emitted light (the FRET signal) depends on the distance and orientation between the two dyes. The research team attached the fluorescent dyes with proteins involved in the cellular response to DNA damage, namely the H2AX substrate and BRCT1 domain. The H2AX substrate is a target for the H2AX protein to bind and become phosphorylated (forming γH2AX).

On the other hand, the BRCT1 domain serves as a site for the collection of repair proteins, including γH2AX. Thus, when a DSB occurs, γH2AX is attracted to the BRCT1 domain, resulting in a conformational change in the fluorescent proteins, thus resulting in a change in the FRET signal. The researchers then proceeded to confirm the validity of the sensor by introducing plasmids (DNA that, here, contains instructions to make the FRET sensor inside the cells) encoding the FRET sensor into human embryonic kidney cells (HEK293T) cells. The biosensor was found to be more sensitive at reacting to the presence of γH2AX than conventional immunostaining techniques, thus making it better at detecting drug- and radiation-induced DSBs.

"The biosensor we have designed could be useful in areas such as cancer treatment and drug discovery," said Associate Professor Tae-Jin Kim, from Pusan National University, Korea, who led the study. "Moreover, as changes in the FRET signal give useful indications of the extent of the DNA damage, the sensor can also be used to examine DNA damage and repair mechanisms, optimize cancer treatments, discover and assess DNA repair drugs, and identify DNA damaging factors in the environment."

Related Links:
Pusan National University

Gold Supplier
Multichannel Pipettes
Finnpipette Novus
Syphilis Rapid Test
ACON Syphilis Rapid Test
Automated Electrolyte Analyzer
Mycoplasma Pneumoniae Assay

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.